Chemours (CC) Competitors

Chemours (NYSE:CC) and AdvanSix (NYSE:ASIX) are both basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

Do institutionals & insiders hold more shares of CC or ASIX?

76.3% of Chemours shares are owned by institutional investors. Comparatively, 86.4% of AdvanSix shares are owned by institutional investors. 0.5% of Chemours shares are owned by company insiders. Comparatively, 5.6% of AdvanSix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Is CC or ASIX more profitable?

AdvanSix has a net margin of 5.10% compared to Chemours' net margin of -7.19%. Chemours' return on equity of 35.14% beat AdvanSix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemours	-7.19%	35.14%	2.45%
AdvanSix	5.10%	10.02%	4.97%

Do analysts recommend CC or ASIX?

Chemours presently has a consensus price target of $18.50, suggesting a potential upside of 31.56%. AdvanSix has a consensus price target of $33.50, suggesting a potential upside of 66.56%. Given AdvanSix's stronger consensus rating and higher possible upside, analysts plainly believe AdvanSix is more favorable than Chemours.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemours	2 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.30
AdvanSix	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Which has more volatility & risk, CC or ASIX?

Chemours has a beta of 1.65, meaning that its share price is 65% more volatile than the S&P 500. Comparatively, AdvanSix has a beta of 1.64, meaning that its share price is 64% more volatile than the S&P 500.

Which has better valuation & earnings, CC or ASIX?

Chemours has higher revenue and earnings than AdvanSix. Chemours is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemours	$5.85B	0.36	$86M	-$2.80	-5.02
AdvanSix	$1.52B	0.36	$44.15M	$2.84	7.08

Does the media prefer CC or ASIX?

In the previous week, Chemours had 1 more articles in the media than AdvanSix. MarketBeat recorded 4 mentions for Chemours and 3 mentions for AdvanSix. Chemours' average media sentiment score of 1.05 beat AdvanSix's score of 0.97 indicating that Chemours is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemours	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AdvanSix	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is CC or ASIX a better dividend stock?

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.5%. AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 3.2%. Chemours pays out -12.5% of its earnings in the form of a dividend. AdvanSix pays out 22.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. AdvanSix has raised its dividend for 2 consecutive years. AdvanSix is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

AdvanSix beats Chemours on 10 of the 19 factors compared between the two stocks.